Zai Lab (ZLAB) Change in Acquisitions & Divestments (2019 - 2025)
Zai Lab (ZLAB) posted Change in Acquisitions & Divestments of $330.0 million for Q1 2025, up 1924.54% sequentially from $16.3 million in Q1 2024, and up 1924.54% YoY from $16.3 million in Q1 2024.
Analysis
Zai Lab (ZLAB) Change in Acquisitions & Divestments (2019 - 2025) Analysis & Trends
Zai Lab has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $330.0 million in Q1 2025.
- Quarterly Change in Acquisitions & Divestments rose 1924.54% year-over-year to $330.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $330.0 million (up 1924.54% YoY) and the FY2025 annual result came in at $330.0 million, up 1924.54% from the prior year.
- Change in Acquisitions & Divestments improved to $330.0 million in Q1 2025 per ZLAB's latest filing, from $16.3 million in the prior quarter.
- Over five years, Change in Acquisitions & Divestments peaked at $743.9 million in Q1 2021 and troughed at $15.3 million in Q4 2023.
- A 5-year average of $191.3 million and a median of $42.2 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 96.89% in 2023, then soared 1924.54% in 2025.
- Over 5 years, Change in Acquisitions & Divestments stood at $743.9 million in 2021, then decreased by 22.67% to $575.3 million in 2022, then sank by 97.34% to $15.3 million in 2023, then rose by 6.54% to $16.3 million in 2024, then jumped by 1924.54% to $330.0 million in 2025.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $330.0 million, $16.3 million, and $15.3 million for Q1 2025, Q1 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 330.00 Mn |
| Mar 31, 2024 | 16.30 Mn |
| Dec 31, 2023 | 15.30 Mn |
| Sep 30, 2023 | 17.90 Mn |
| Jun 30, 2023 | 35.05 Mn |
| Mar 31, 2023 | 49.45 Mn |
| Sep 30, 2022 | 575.27 Mn |
| Jun 30, 2022 | 30.00 Mn |
| Mar 31, 2022 | 100.00 Mn |
| Mar 31, 2021 | 743.90 Mn |
| Jun 30, 2020 | 150.00 Mn |
| Mar 31, 2020 | 50.00 Mn |
| Dec 31, 2019 | 77.64 Mn |
| Sep 30, 2019 | 100.00 Mn |